From: Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis
Dimension | Included studies | # of patients | SMD | 95% CI | p value |
---|---|---|---|---|---|
Physical functioning | 1116 | 0,65 | −0,11-1,41 | 0,09 | |
Role functioning | 1116 | 0,63 | 0,05-1,22 | 0,04 | |
Emotional functioning | 1116 | 0,52 | −0,10 − 1,13 | 0,1 | |
Cognitive functioning | 779 | 0,46 | − 0,21 − 1,13 | 0,18 | |
Social functioning | 779 | 0,62 | 0,22-1,03 | 0,002 | |
Fatigue | 779 | −0,79 | −1,66 − 0,08 | 0,08 | |
Nausea/Vomitting | 1247 | − 0,55 | -1-(− 0,1) | 0,02 | |
Pain | 1116 | − 0,86 | − 1,54-(− 0,18) | 0,01 | |
Dyspnea | 779 | −0,37 | -0,65-(− 0,09) | 0,009 | |
Insomnia | 1247 | -0,54 | −1,23 − 0,14 | 0,12 | |
Appetite loss | 1247 | −0,62 | -1,29 − 0,05 | 0,07 | |
Constipation | 779 | − 0,14 | −0,41-0,13 | 0,31 | |
Diarrhea | 779 | -0,43 | -0,86-0,01 | 0,05 | |
Financial difficulties | 713 | -0,69 | −1,21-(− 0,16) | 0,01 |